THRIVE-CAR-T Digital App
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Patrick C. Johnson, MD
- Study ID
- NCT06665295
- Status
- Recruiting
Conditions
- CAR T-Cell Therapy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- THRIVE-CAR-T — BEHAVIORALThe intervention will begin several weeks prior to CAR-T cell therapy and will continue up until 30 days post CAR-T cell therapy. THRIVE-CAR-T is an educational and interactive digital application on an iPad for patients as they navigate receiving CAR-T. THRIVE-CAR-T is self-administered and provides education about the CAR-T cell therapy process, with several features to promote coping skills training informed by various well-established supportive psychotherapy strategies (e.g., cognitive behavior therapy, mindfulness, positive psychology), engagement, and health behavior change including gamification strategies, videos of patients who received CAR-T, and optional content.
Study Details
The goal of this clinical trial is to learn if a digital mobile application called THRIVE-CAR-T is helpful for the care of patients undergoing CAR-T cell therapy. The main question\[s\] it aims to answer are whether the THRIVE-CAR-T app is feasible and acceptable to patients.
Key Dates
- Start date
- Oct 17, 2024
- Status verified
- Mar 2026
- Primary completion
- Nov 1, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: Usual CareUsual care at our institution involves a teaching visit with a nurse navigator and written handouts.
- Experimental: THRIVE-CAR-T plus usual carePatients receiving the THRIVE-CAR-T intervention will receive usual care and will use the THRIVE-CAR-T digital application on an iPad when planned to receive CAR-T.
Primary Outcome Measure
Feasibility [ Time Frame: Through study completion, an average of 2 years ]
Central Contacts
- Patrick C Johnson, MD6177244000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 |
Find similar trials in Boston, MA
By research site
Related Studies
- Exercise as an Immune Adjuvant for Allogeneic Cell TherapiesEARLY_PHASE1 · Recruiting · University of Arizona · Tucson, Arizona
- Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell TherapyRecruiting · University of California, San Diego · La Jolla, California